Researching | Chinese Journal of Cancer Biotherapy

Chinese Journal of Cancer Biotherapy

CN

31-1725/R

ISSN

1007-385X

Frequency

Monthly issues

Submit a Paper

Research progress on the antitumor molecular mechanisms of usnic acid and the challenges and countermeasures in its therapeutic application

[in Chinese], [in Chinese], and [in Chinese]

Aug. 26, 2025Chinese Journal of Cancer Biotherapy

DOI：10.3872/j.issn.1007-385x.2025.07.016

Advances in the research and application of combination therapy strategies targeting the PD-1/PD-L1 pathway in chondrosarcoma treatment

[in Chinese], and [in Chinese]

Aug. 26, 2025Chinese Journal of Cancer Biotherapy

DOI：10.3872/j.issn.1007-385x.2025.07.015

Research progress of tumor-associated macrophages in lung cancer immunotherapy

[in Chinese], [in Chinese], and [in Chinese]

Aug. 26, 2025Chinese Journal of Cancer Biotherapy

DOI：10.3872/j.issn.1007-385x.2025.07.014

Research progress on the role and mechanisms of IL-33/ST2 signaling pathyway in gastrointestinal tumors

[in Chinese], and [in Chinese]

Aug. 26, 2025Chinese Journal of Cancer Biotherapy

DOI：10.3872/j.issn.1007-385x.2025.07.013

Association between cancer-related fatigue and PD-1 inhibitors in patients with malignant melanoma and its influencing factors

GAO Wenhua, YANG Fuli, and ZHANG Jinzhong

Aug. 26, 2025Chinese Journal of Cancer Biotherapy

DOI：10.3872/j.issn.1007-385x.2025.07.012

Top Downloads

Mechanism of bexarotene in suppressing double hit lymphoma via modulation of the c-Myc pathway: Insights from WGCNA

Chinese Journal of Cancer BiotherapyVol. 32, Issue 7, 716 (2025)

Screening and identification of HLA-G tumor-targeting ankyrins based on phagedisplay technology

Chinese Journal of Cancer BiotherapyVol. 32, Issue 7, 689 (2025)

Mechanism of CAPN4-mediated cancer stem cell stemness in cisplatin resistance in lung adenocarcinoma

Chinese Journal of Cancer BiotherapyVol. 32, Issue 7, 681 (2025)

ENO1 promotes gastric cancer progression by regulating alternative splicing of PKM

Chinese Journal of Cancer BiotherapyVol. 32, Issue 7, 706 (2025)

Toosendanin inhibits the malignant biological behaviors of esophageal squamous cell carcinoma KYSE150 cells by downregulating HIF1A expression via the AKT/mTOR pathway

Chinese Journal of Cancer BiotherapyVol. 32, Issue 7, 723 (2025)

2',4'-dihydroxychalcone inhibits the proliferation and migration of colorectal cancer cells by regulating miR-7-5p-induced autophagy

Chinese Journal of Cancer BiotherapyVol. 32, Issue 7, 698 (2025)